🟢 Milestone Pharmaceuticals is trading 5% up in pre-market — catalyst unconfirmed

Milestone Pharmaceuticals is trading at $0.74, up 5.29%, in pre-market; the catalyst remains unconfirmed.

• No verified company announcement directly explains the rise; the latest listed release was October 19 and concerned conference presentations.
• An October 23 article noted a lower average fair-value estimate and a Raymond James price-target cut, but linked neither to this move.
• The provided market indices were lower; pre-market volume was not verified.